Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCP) Cash & Equivalents (2016 - 2026)

Chs (CHSCP) has disclosed Cash & Equivalents for 17 consecutive years, with $248.5 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents fell 42.66% to $248.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $248.5 million through Feb 2026, down 42.66% year-over-year, with the annual reading at $327.8 million for FY2025, 58.76% down from the prior year.
  • Cash & Equivalents hit $248.5 million in Q1 2026 for Chs, down from $374.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.8 billion in Q3 2023 to a low of $211.9 million in Q1 2022.
  • Historically, Cash & Equivalents has averaged $616.6 million across 5 years, with a median of $450.5 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: soared 170.09% in 2023 and later tumbled 68.9% in 2024.
  • Year by year, Cash & Equivalents stood at $636.3 million in 2022, then soared by 112.13% to $1.3 billion in 2023, then tumbled by 66.62% to $450.5 million in 2024, then dropped by 16.83% to $374.7 million in 2025, then tumbled by 33.69% to $248.5 million in 2026.
  • Business Quant data shows Cash & Equivalents for CHSCP at $248.5 million in Q1 2026, $374.7 million in Q4 2025, and $327.8 million in Q3 2025.